Previous Close | 3.4700 |
Open | 2.6300 |
Bid | 3.3000 |
Ask | 3.6000 |
Strike | 195.00 |
Expire Date | 2024-07-19 |
Day's Range | 2.6300 - 3.5000 |
Contract Range | N/A |
Volume | |
Open Interest | 951 |
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.